000 04269nam a22004575i 4500
001 60496
005 20200226102257.0
007 cr nn 008mamaa
008 170922s2017 gw | s |||| 0|eng d
020 _a9783319598567
_9978-3-319-59856-7
024 7 _a10.1007/978-3-319-59856-7
_2doi
035 _a(DE-He213)978-3-319-59856-7
050 4 _aRG133.5
072 7 _aMFKC
_2bicssc
072 7 _aHEA039060
_2bisacsh
082 0 4 _a612.6
_223
245 1 0 _aBiomarkers for Endometriosis
_h[electronic resource] :
_bState of the Art /
_cedited by Thomas D'Hooghe.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2017.
300 _aXII, 267 p. 8 illus., 3 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aBiomarker development: general concepts and state of the art in medicine -- Biomarker development in chronic inflammatory diseases -- Biomarker development in cancer -- Biomarker development in ovarian cancer -- Biomarker development in  endometrial cancer -- Biomarker development in breast cancer -- Biomarker development in reproductive medicine -- Industry perspective on biomarker development in medicine -- Biomarker development in endometriosis -- Health economic impact of endometriosis -- Patient perspective on biomarker development for endometriosis -- Genetic biomarkers for endometriosis -- Epidemiological and clinical risk factors for endometriosis -- Peripheral blood biomarkers for endometriosis -- Endometrial biomarkers for endometriosis -- Biomarkers for endometriosis in saliva, urine and peritoneal fluid -- mRNA and miRNA biomarkers for endometriosis -- Proteomic biomarkers for endometriosis -- Multiprotein arrays and endometriosis -- Metabolomics and endometriosis -- Harmonization of clinical and laboratory data to improve biomarker discovery in endometriosis -- Endometriomics and biomarker development  in endometriosis.
520 _aThis book presents an overview of the diagnostic performance of non- or semi-invasive tests for endometriosis in peripheral blood, endometrium, saliva, peritoneal fluid and urine. The value of existing and emerging systems biology technologies for biomarker development is addressed in several chapters on genetics, microarrays, proteomics and metabolomics. Although tests with high sensitivity and acceptable specificity have been developed, sometimes validated in independent populations and seem promising, more research is needed to translate these data into clinical benefit for patients and coordinate efforts internationally to standarize analysis, reports and operating procedures. The gold standard to diagnose endometriosis is currently through laparoscopic inspection with histological confirmation, a surgical procedure with rare but significant potential risks for the patients. A non-invasive test for endometriosis would be critical for the early detection of endometriosis of symptomatic women with pelvic pain and/or subfertility with normal ultrasound. This would include nearly all cases of minimal-mild endometriosis, some cases of moderate-severe endometriosis without a clearly visible ovarian endometrioma and cases with pelvic adhesions and/or other pelvic pathology, who might benefit from surgery to improve pelvic pain and/or subfertility. Such a test would also be useful in symptomatic women with ultrasound imaging suspicious for endometriosis, since it may be difficult to differentiate an ovarian endometrioma from other ovarian cysts and since the quality of ultrasound imaging is highly variable worldwide.
650 0 _aMedicine.
650 0 _aHuman genetics.
650 0 _aReproductive medicine.
650 0 _aBioinformatics.
650 1 4 _aMedicine & Public Health.
650 2 4 _aReproductive medicine.
650 2 4 _aBioinformatics.
650 2 4 _aHuman genetics.
700 1 _aD'Hooghe, Thomas.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783319598543
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-319-59856-7
912 _aZDB-2-SME
999 _c946
_d946